Cargando…
Low c-Kit expression identifies primitive, therapy-resistant CML stem cells
Despite the efficacy of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML), malignant long-term hematopoietic stem cells (LT-HSCs) persist as a source of relapse. However, LT-HSCs are heterogenous and the most primitive, drug-resistant LT-HSC subpopulations are not well characterize...
Autores principales: | Shah, Mansi, Kumar, Harish, Qiu, Shaowei, Li, Hui, Harris, Mason, He, Jianbo, Abraham, Ajay, Crossman, David K., Paterson, Andrew, Welner, Robert S., Bhatia, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870079/ https://www.ncbi.nlm.nih.gov/pubmed/36413413 http://dx.doi.org/10.1172/jci.insight.157421 |
Ejemplares similares
-
Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species
por: Flores‐Lopez, Gabriela, et al.
Publicado: (2018) -
Eradication of CML stem cells
por: Carter, Bing Z., et al.
Publicado: (2016) -
TNF-α-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling
por: Agarwal, Puneet, et al.
Publicado: (2021) -
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
por: von Palffy, Sofia, et al.
Publicado: (2020) -
Metabolic alterations mediated by STAT3 promotes drug persistence in CML
por: Patel, Sweta B., et al.
Publicado: (2021)